Shares of CVS Health Corp. CVS rose 1.67% to $67.46 Friday, on what proved to be an all-around poor trading session for the ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

Elevance Health reported a benefit expense ratio of 86.4% in the first quarter, up 80 bps year over year, mainly because Medicaid rates failed to keep up with medical cost trends. High-cost trends ...

Here is how Adaptive Biotechnologies (ADPT) and CVS Health (CVS) have performed compared to their sector so far this year.

KMG Fiduciary Partners LLC dramatically reduced its investment in CVS Health, selling off 88.1% of its shares. The investor ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

With a market cap of $80.4 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company headquartered in ...

Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $84.00. The company’s shares closed yester ...

The team at Omada Health took a victory lap Friday after the company's successful Nasdaq debut, according to company President Wei-Li Shao. | The team at Omada Health took a victory lap Friday after ...

We recently published a list of Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks. In this article, we are going ...

CVS Health’s stock has been trending on investor radar, but not for all the right reasons—its recent 4% dip contrasts the S&P ...